American Association for Cancer Research

AACR Journal Scopes

CANCER DISCOVERY

CDCancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials. Cancer Discovery is the essential cancer information resource and publishes Review Articles, Perspectives and Commentaries, News, and Research Watch summaries of important journal articles. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies.

Cancer Epidemiology, Biomarkers, & Prevention

CEBPCancer Epidemiology, Biomarkers & Prevention (CEBP) publishes original research on cancer causation, mechanisms of carcinogenesis, prevention, and survivorship. The following topics are of special interest to the readership: descriptive, analytical, and molecular epidemiology; the use of biomarkers to study the neoplastic and pre-neoplastic processes; chemoprevention and other types of prevention trials; and the role of behavioral factors in cancer etiology and prevention.

Cancer Prevention Research

CaPRCancer Prevention Research, the newest journal from the American Association for Cancer Research, is devoted exclusively to cancer prevention. The journal publishes important original studies, reviews, and perspectives within the major topic areas of oncogenesis; risk factors and risk assessment; early detection research; and chemopreventive and other interventions, including the basic science behind these strategies. Cancer Prevention Research comprises preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

Cancer Research

CanResCancer Research is the most frequently cited cancer journal in the world. The journal publishes significant original studies, reviews, and perspectives on all areas of basic, clinical, translational, epidemiologic, and prevention research in cancer and the cancer-related biomedical sciences. Topics include biochemistry; chemical, physical, and viral carcinogenesis and mutagenesis; clinical research, including clinical trials; endocrinology; epidemiology and prevention; experimental therapeutics, molecular targets, and chemical biology; immunology and immunotherapy, including biological therapy; molecular biology, pathobiology, and genetics; radiobiology and radiation oncology; cell and tumor biology; tumor microenvironment; systems biology; and emerging technologies.

Top

 

Clinical Cancer Research

CCRClinical Cancer Research publishes original articles describing clinical research on the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer. Its focus is on innovative clinical and translational research that represents a bridge between the laboratory and the clinic. Clinical Cancer Research is especially interested in clinical trials evaluating new treatments for cancer, research on molecular abnormalities that predict response to therapy and outcome, and laboratory studies of new drugs and biological agents that will lead to clinical trials in patients.

Molecular Cancer Research

CanResPapers submitted to Molecular Cancer Research should reflect the journal’s focus on the molecular and cellular aspects of cancer. Submissions should present significant new information gathered from basic research that has implications for cancer therapeutics in one of the following topic areas: angiogenesis, metastasis, and the cellular microenvironment; cancer genes and genomics; cell cycle, cell death, and senescence; DNA damage and cellular stress responses; model organisms; and signaling and regulation.

Molecular Cancer Therapeutics

MCTMolecular Cancer Therapeutics publishes significant original studies, reviews, meeting reports, and commentaries on areas of basic research that address the relationships between molecular structures, biological activities, and the mechanisms of action of pharmacologic agents in the general area of cancer. Topics include experimental cancer therapeutics; identification of molecular targets; targets for chemoprevention; new models; cancer chemistry; drug discovery and development; molecular and cellular pharmacology and pharmacogenomics, surrogate markers and molecular classification of tumors; and bioinformatics and computational molecular biology.


Top